Nebuliser which would be used to treat cystic fibrosis

New trial seeks to reduce cystic fibrosis treatment burden

Researchers at the University of Liverpool and Alder Hey Children’s Hospital are set to begin a new clinical trial aimed at improving the lives of people with cystic fibrosis (CF).

NIHR has awarded funding to the study through the NIHR Health Technology Programme.

The study which will seek to address how the treatment burden for people with CF could be safely reduced - an ambition which has been identified by patients and their healthcare teams as a top research priority.

For many people with CF, their care can involve spending many hours each day on multiple treatments, including aerosolised therapies delivered by nebulisers, to keep their lungs stable and prevent chest infections.

Recently the UK approved and introduced a highly-effective triple therapy drug, suitable for many people with CF, which provides researchers with an ideal opportunity to more robustly explore potential reductions in treatment burden.

The CF STORM clinical trial will enrol people with the condition from across the UK who have been established on the new drug combination and take a daily nebulised muco-active therapy.

It will then look to evaluate whether their daily treatment regime can be rationalised without a significant reduction in their respiratory function.

Professor Kevin Southern from the University of Liverpool and Dr Gwyneth Davies from University College London will lead the clinical trial, which is set to be run by the Liverpool Clinical Trials Centre.

Professor Southern, from the Department of Women’s and Children’s Health, said: “As transformative therapies emerge for CF and other conditions it is important that we evaluate rigorously the impact on the patient journey”.

NHE Jan.Feb 21

NHE Jan/Feb 21

Creating a net zero NHS

NHE’s Jan/Feb 2021 edition focuses on the role of pharma working alongside the NHS, how we are working to digitise the health service and the ways in which the NHS can be involved in addressing the climate emergency.


View all videos
BMC Whitepaper


How well do the NHS understand digital potential?

Recently we have been gathering primary data direct from those within the NHS on modernising NHS technology and the challenges faced around resource, training and service management.

Download the full whitepaper and read the full findings in our exclusive report to learn more.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all